On-demand male contraception via acute inhibition of soluble adenylyl cyclase.
Saved in:
| Title: | On-demand male contraception via acute inhibition of soluble adenylyl cyclase. |
|---|---|
| Authors: | Balbach M; Department of Pharmacology, Weill Cornell Medicine, New York, NY, USA., Rossetti T; Department of Pharmacology, Weill Cornell Medicine, New York, NY, USA., Ferreira J; Department of Pharmacology, Weill Cornell Medicine, New York, NY, USA., Ghanem L; Department of Pharmacology, Weill Cornell Medicine, New York, NY, USA., Ritagliati C; Department of Pharmacology, Weill Cornell Medicine, New York, NY, USA., Myers RW; Tri-Institutional Therapeutics Discovery Institute, New York, NY, USA., Huggins DJ; Tri-Institutional Therapeutics Discovery Institute, New York, NY, USA.; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA., Steegborn C; Department of Biochemistry, University of Bayreuth, Bayreuth, Germany., Miranda IC; Laboratory of Comparative Pathology, Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center, and The Rockefeller University, New York, NY, USA., Meinke PT; Department of Pharmacology, Weill Cornell Medicine, New York, NY, USA.; Tri-Institutional Therapeutics Discovery Institute, New York, NY, USA., Buck J; Department of Pharmacology, Weill Cornell Medicine, New York, NY, USA. jobuck@med.cornell.edu., Levin LR; Department of Pharmacology, Weill Cornell Medicine, New York, NY, USA. |
| Source: | Nature communications [Nat Commun] 2023 Feb 14; Vol. 14 (1), pp. 637. Date of Electronic Publication: 2023 Feb 14. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
